UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K/A
(Amendment No. 1)
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported):  August 28, 2014
 
Applied DNA Sciences, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
002-90539
59-2262718
(State or other jurisdiction
 (Commission File Number)
(IRS Employer
of incorporation)
  
Identification No.)
 
50 Health Sciences Drive
Stony Brook, New York 11790
(Address of principal executive offices; zip code)
 
Registrant’s telephone number, including area code:
631-240-8800
 
N/A
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
   
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d 2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 

 
Explanatory Note
 
This Amendment No. 1 to the Current Report on Form 8-K/A (this “Amendment”) is filed by Applied DNA Sciences, Inc. (the “Company”) in order to amend the Current Report on Form 8-K filed by the Company on September 4, 2014 (the “Original Filing”), reporting under Item 1.01 the entry into a material definitive agreement (the “Agreement”) by the Company. The purpose of this Amendment is to file the Agreement, which has not previously been filed, as an exhibit under Item 9.01. No other changes are made to the Original Filing.
 
Item 9.01. Financial Statements and Exhibits
 
(d) Exhibits
 
10.1
Form of Award/Contract awarded by Office of Secretary of Defense on behalf of Defense Logistics Agency  dated August 28, 2014
 
- 2 -
 

 

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:  September  8, 2014
 APPLIED DNA SCIENCES, INC.
     
  By:
  /s/ James A. Hayward
 
Name:
James A. Hayward
 
Title:
Chief Executive Officer
 
- 3 -
 

 

 
EXHIBIT INDEX
 
Exhibit No.
  
Description
10.1
  
Form of Award/Contract awarded by Office of Secretary of Defense on behalf of Defense Logistics Agency  dated August 28, 2014
 
- 4 -